PAROXETINE ALMUS 20 mg, film-coated tablet scored 14 tablets, CIP 3400937426763
Active ingredients: Paroxetine hydrochloride, Paroxetine
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored14 tablets, CIP 3400937426763orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PAROXETINE ALMUS 20 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- pilulier(s) polypropylène avec fermeture de sécurité enfant de 14 comprimé(s)
- Marketing authorisation holder
- ALMUS FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 27 Jun 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64941258CIP73742676CIP133400937426763Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE PAROXÉTINE ANHYDREcomprimé | — | SA |
| PAROXÉTINE BASEcomprimé | 20 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.